Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape

Immunotherapy has led to a paradigm shift in the treatment of many advanced malignancies. Despite the success in treatment of tumors like non-small cell lung cancer (NSCLC) and melanoma, checkpoint inhibition-based immunotherapy has limitations. Many tumors, such as pancreatic cancer, are less respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Osipov, Arsen, Saung, May Tun, Zheng, Lei, Murphy, Adrian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704558/
https://www.ncbi.nlm.nih.gov/pubmed/31439034
http://dx.doi.org/10.1186/s40425-019-0667-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704558/
https://www.ncbi.nlm.nih.gov/pubmed/31439034
http://dx.doi.org/10.1186/s40425-019-0667-0

Ejemplares similares